MDB Capital Holdings, LLC (MDBH)
| Market Cap | 33.76M -21.5% |
| Revenue (ttm) | 4.13M +15.5% |
| Net Income | -21.39M |
| EPS | -2.12 |
| Shares Out | 10.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 5,515 |
| Open | 3.278 |
| Previous Close | 3.261 |
| Day's Range | 3.278 - 3.278 |
| 52-Week Range | 2.749 - 5.500 |
| Beta | 1.22 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 14, 2026 |
About MDBH
MDB Capital Holdings, LLC, through its subsidiaries, primarily operates as a broker-dealer. The company operates in two segments, Broker Dealer & Intellectual Property Service, and Technology Development. The Broker Dealer & Intellectual Property Service segment operates as a full-service broker dealer firm, which focuses on conducting private and public security offerings, as well as providing research services for investment banking due diligence. The Technology Development segment develops a small molecule senescence platform. It provides se... [Read more]
Financial Performance
Financial StatementsNews
MDB Capital to Present at Planet MicroCap Las Vegas 2026 Along with Subsidiary PatentVest and Portfolio Company Buda Juice
Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) today announced that its CEO & Co-Founder, Chris Marlett, will present live at the Planet MicroCap Las Vegas ...
PatentVest Launches New Case Studies Section Featuring Strategic AI IP Engagement with Docana
Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with...
MDB Capital Holdings, LLC Quarterly report: Q1 2026
MDB Capital Holdings, LLC has published its Q1 2026 quarterly earnings report on May 14, 2026.
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market
DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, “The Triple-Agonist Race: Retatrutide...
Retatrutide Crosses the Surgical Threshold, but the Real Race Has Just Started
Dallas, TX, April 29, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse: “The Last 20%: Retatrutide, the Glucagon Paradox, and the Race to Own Surgery-Level Weight Loss Wi...
MDB Capital Holdings, LLC Earnings Call Transcript: Q4 2025
Management is optimistic about scaling company launches using AI, with four principal assets poised for significant value creation. Operating expenses are expected to decrease post-spinout of MDB Direct and PatentVest, while distribution and execution risks remain key challenges.
MDB Capital Holdings, LLC Shareholder letter: Q4 2025
MDB Capital Holdings, LLC has published a letter to shareholders covering Q4 2025, which was released on March 31, 2026.
MDB Capital Holdings, LLC Annual report: Q4 2025
MDB Capital Holdings, LLC has published its Q4 2025 annual report on March 31, 2026.
MDB Capital Holdings, LLC Slides: Q4 2025
MDB Capital Holdings, LLC has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 31, 2026.
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
Dallas, TX, March 31, 2026 (GLOBE NEWSWIRE) -- PatentVest today released its latest PatentVest Pulse report, “The Amylin Renaissance: Forty Programs, $19 Billion in Deals, and the Race to Build the Ne...
PatentVest Highlights New Legal Article on AI Patenting Strategy by Senior Patent Attorney Sarah Cork
Dallas, TX, March 30, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced a new addition to its IP Legal Insights section on the company website, a platform dedicated to sharing expert legal perspecti...
MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time
Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plan...
MDB Capital Holdings, LLC Slides: Investor presentation
MDB Capital Holdings, LLC has posted slides in relation to its latest quarterly earnings report, which was published on March 12, 2026.
PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics
Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing ...
PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race
Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be Analysis of 1,200+ patent documents reveal which programs are building durable exclusiv...
MDB Capital Holdings Announces Transitions In Its Board of Directors
MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service MDB Capital Holdings Announ...
PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy
New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezo...
Keiretsu Forum and MDB Capital Close 2025 With High-Impact Investor Summits, and Announces Expanded Summit Series for 2026
Keiretsu Forum MST and MDB Capital united 150+ investors to improve syndication and exits, and will expand the Investor Summit series nationwide in 2026.
MDB Capital Holdings, LLC Earnings Call Transcript: Q3 2025
Strong pipeline and operational scaling are expected to drive three to five launches next year, with significant equity positions in Pollex Bio, Buda Juice, Exazyme, and Heartbeat offering substantial upside. Market conditions are challenging but anticipated to improve, supporting a bullish outlook.
MDB Capital Holdings, LLC Earnings release: Q3 2025
MDB Capital Holdings, LLC released its Q3 2025 earnings on November 20, 2025, summarizing the period's financial results.
MDB Capital Holdings, LLC Quarterly report: Q3 2025
MDB Capital Holdings, LLC has published its Q3 2025 quarterly earnings report on November 20, 2025.
MDB Capital Holdings, LLC Slides: Q3 2025
MDB Capital Holdings, LLC has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 20, 2025.
MDB Capital Holdings Provides Third Quarter 2025 Update
Addison, TX, Nov. 20, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides a...
MDB Capital Holdings, LLC Proxy statement: Proxy Filing
MDB Capital Holdings, LLC filed a proxy statement on November 14, 2025, providing details for shareholder voting and corporate governance matters.
MDB Capital Holdings to Host Third Quarter 2025 Update Conference Call on Thursday November 20, 2025, at 4:30 p.m. Eastern Time
Addison, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans...